This year's MIT Sloan BioInnovations Conference will be taking place on March 12, 2010 at the Boston Marriott Cambridge. BioInnovations is the premier forum for leading thinkers from industry, academia, and government to discuss the next wave of innovations in life science technology, policy, and commercialization.
Keynote Speakers: Dr. Robert Langer of MIT; Peter Wirth, EVP of Genzyme; and Matthew Emmens, CEO of Vertex.
The Panel Discussions will include: Bringing Innovation to Market Emerging Markets: The future of Pharma growth Beyond Electronic Medical Records: Building Collaborative Networks Healthcare Reform in Limbo.
Register by March 1 for Early-Bird Discounts!
For more information, contact: Jennifer Woodfin
The meeting is sponsored by Genentech Mintz Levin MIT Sloan BioMedical Business Club
The Media Partner is Xconomy
About the MIT Sloan BioMedical Business Club The MIT Sloan BioMedical Business Club is a student-run organization that promotes leadership and involvement in the life science industries comprised of biotechnology, pharmaceuticals, medical devices and healthcare. We are a forum for ideas and actions linking students, scientists, and professionals from leading universities, businesses, and non-profit organizations.
